companyName


Citius Pharmaceuticals, Inc. Website Screenshot

http://www.citiuspharma.com

Citius Pharmaceuticals, Inc. Company Intro

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Industry

Healthcare

Citius Pharmaceuticals, Inc. Headquaters

11 Commerce Drive
Cranford,07016
United States


Citius Pharmaceuticals, Inc. Share price

14 Sep 2022 09:00 GMT

$1.3000

-0.02 (-1.52 %)


Citius Pharmaceuticals, Inc. Market cap

$186.918 M


WMC RANKING

2022

Citius Pharmaceuticals, Inc. # 473

Biotechnology

Latest Citius Pharmaceuticals, Inc. News

News 04 Dec 2022

FDA Accepts BLA for Denileukin Diftitox in Cutaneous ...

Citius Pharmaceuticals, Inc. announces U.S. Food and Drug Administration acceptance of biologics license application of denileukin diftitox for the...

News 04 Dec 2022

FDA Accepts BLA for Denileukin Diftitox in Cutaneous ...

Citius Pharmaceuticals, Inc. announces U.S. Food and Drug Administration acceptance of biologics license application of denileukin diftitox for the...

News 02 Dec 2022

As the world becomes increasingly uncertain, Citius ...

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) closed the day trading at $1.23 up 5.13% from the previous closing price of $1.17. In other words, the price has...


WMC Market Score


WMC Market to Revenue Score


Citius Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Citius Pharmaceuticals, Inc. USD $0 $21,174 $-21,070 $1,869M 473
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Citius Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Citius Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors




Citius Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Citius Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Citius Pharmaceuticals, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Citius Pharmaceuticals, Inc. 0 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries